Congruence secures a $5 million grant to advance innovative therapies for GBA1 Parkinson's disease, enhancing hope for ...

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

The side effects that come with many cancer treatments can cause people to delay or avoid treatment.

Unlock the secrets of executive presence in pharma to inspire confidence, influence decisions, and elevate your leadership ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Emrelis is accelerating investor interest, validating biomarker-driven ADCs, and shaping distinct strategic ...